CIRRHOSIS, LIVER
Clinical trials for CIRRHOSIS, LIVER explained in plain language.
Never miss a new study
Get alerted when new CIRRHOSIS, LIVER trials appear
Sign up with your email to follow new studies for CIRRHOSIS, LIVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herb formula aims to block deadly liver cancer
Disease control Not yet recruitingThis study is testing whether adding a traditional Chinese herbal formula called Fufang Biejiaruangan to standard antiviral treatment can help prevent liver cancer in people with hepatitis B-related cirrhosis. Researchers will enroll over 1,000 patients at high risk for cancer an…
Matched conditions: CIRRHOSIS, LIVER
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Can a Low-Dose cancer drug stop liver cancer before it starts?
Prevention Not yet recruitingThis study is testing whether a low dose of the cancer drug erlotinib can prevent liver cancer from developing in people who have advanced liver scarring (cirrhosis). Sixty participants will be randomly assigned to receive either the drug or a placebo for one year. Researchers wi…
Matched conditions: CIRRHOSIS, LIVER
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Apr 01, 2026 14:42 UTC
-
Doctors launch major study to predict dangerous bleeding in liver patients
Knowledge-focused Not yet recruitingThis study aims to better understand when and why patients with severe liver pressure (portal hypertension) bleed during planned medical procedures. It will follow 2500 patients to track bleeding events and identify which patient and procedure factors are most predictive of risk.…
Matched conditions: CIRRHOSIS, LIVER
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC